Emerging pharmacotherapy for cancer patients with cognitive dysfunction

Advances in the diagnosis and multi-modality treatment of cancer have increased survival rates for many cancer types leading to an increasing load of long-term sequelae of therapy, including that of cognitive dysfunction. The cytotoxic nature of chemotherapeutic agents may also reduce neurogenesis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Justin, Ahlberg, Fiona M, Berk, Michael, Ashley, David M, Khasraw, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015674/
https://www.ncbi.nlm.nih.gov/pubmed/24156319
http://dx.doi.org/10.1186/1471-2377-13-153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015674/
https://www.ncbi.nlm.nih.gov/pubmed/24156319
http://dx.doi.org/10.1186/1471-2377-13-153

Ejemplares similares